NDC 71336-1002 – Oxlumo

Lumasiran Sodium 94.5 mg/.5mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC71336-1002

Product details

Brand name
Oxlumo
Generic name
Lumasiran
Labeler
Alnylam Pharmaceuticals, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA214103
Marketed since
November 23, 2020
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Oxlumo →

Package NDC codes (1)

Package NDCDescriptionSince
71336-1002-11 VIAL, SINGLE-USE in 1 CARTON (71336-1002-1) / .5 mL in 1 VIAL, SINGLE-USENov 23, 2020